Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 4Phase 1 4Phase 3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 4Gastrointestinal 4Thoracic 1Sarcoma 1Plasma cell 1Dermatologic 1

Conditions

Pancreatic Neoplasms 3Rectal Neoplasms 1Colonic Neoplasms 1

Interventions

Gemcitabine 218Fluorouracil 142Oxaliplatin 132Capecitabine 122pembrolizumab 113Irinotecan 110Leucovorin 104Bevacizumab 98Nivolumab 80Cisplatin 80130-nm albumin-bound paclitaxel 80Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 50Carboplatin 47Magnetic Resonance Spectroscopy 44Specimen Handling 39Docetaxel 37Taxes 36fludarabine 34Radiation 34durvalumab 33Ipilimumab 33Erlotinib Hydrochloride 33Biopsy 33Radiosurgery 27Folfox protocol 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × devimistat × Gastrointestinal × Clear all
NCT02232152 2023-08-07

CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Wake Forest University Health Sciences

Phase 1 Completed
19 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT01835041 2023-07-12

CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer

Wake Forest University Health Sciences

Phase 1 Completed
21 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01839981 2018-12-27

CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Wake Forest University Health Sciences

Phase 1 Completed
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03435289 2018-02-19

A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer

Atlantic Health System

Phase 1 Unknown
24 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡